InsidersTradesSigma
Track the Novonesis (Novozymes A/S) share price and the full directors' dealings record of the company, a listed equity based in Denmark. Shares are quoted on the DK market, under the oversight of Finanstilsynet DK. Operating in the Chemicals sector, Novonesis (Novozymes A/S) has published 0 insider filings. Market capitalisation: €191.2bn. The full history is free.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Novonesis (Novozymes A/S) Buy (bullish), based on 16 analysts. Average price target: DKK 466.06.
Fundamental score
Ranked 15,292 of 29,302 companies
50.8
score / 100
Value37
Quality64
FCF yld0.4%
Earn yld0.3%
EV/EBITDA·
ROE5.4%
Gross mgn54%
Net mgn14%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Declarations0 total
No declarations found
0 of 0 declarations
About Novonesis (Novozymes A/S)
Novonesis is a biotechnology company focused on developing enzymatic solutions for various sectors. It is part of Novozymes A/S, a global leader in enzymes and microorganisms.